 The Firazyr Patient Registry is a prospective, observational study designed to document the routine clinical outcomes over time in patients treated with Firazyr in countries where it is currently approved. The data collected will be used to evaluate the safety of Firazyr in routine clinical practice and as a data source for post-marketing investigations. 